GoodRx Holdings Inc

Glossary of Selected Terminology

As used in this Annual Report on Form 10-K, unless the context otherwise requires, references to:

•“we,” “us,” “our,” the “Company,” “GoodRx,” and similar references refer to GoodRx Holdings, Inc. and its

consolidated subsidiaries.

•“Co-Founders” refers to Trevor Bezdek, our Co-Chairman and a director of the Company, and Douglas Hirsch,

a director of the Company.

•“consumers” refer to the general population in the United States that uses or otherwise purchases healthcare

products and services. References to “our consumers” or “GoodRx consumers” refer to consumers that

have used one or more of our offerings.

•“discounted price” refers to a price for a prescription provided on our platform that represents a negotiated

rate provided by one of our PBM partners at a retail pharmacy or under a direct contract with one of our

partner pharmacies. Through our platform, our discounted prices are free to access for consumers by saving a

GoodRx code to their mobile device for their selected prescription and presenting it at the chosen pharmacy.

The term “discounted price” excludes prices we may otherwise source, such as prices from patient assistance

programs for low-income individuals and Medicare prices, and any negotiated rates offered through our

subscription offerings: GoodRx Gold (“Gold”), and Kroger Rx Savings Club powered by GoodRx (“Kroger

Savings”) which sunset in July 2024.

•“Francisco Partners” refers to investment funds associated with Francisco Partners, including Francisco

Partners IV, L.P. and Francisco Partners IV-A, L.P.

•“GoodRx code” refers to codes that can be accessed by our consumers through our apps or websites or that

can be provided to our consumers directly by healthcare professionals, including physicians and pharmacists,

that allow our consumers free access to our discounted prices or a lower list price for their prescriptions when

such code is presented at their chosen pharmacy.

•“Monthly Active Consumers” refers to the number of unique consumers who have used a GoodRx code to

purchase a prescription medication in a given calendar month and have saved money compared to the list

price of the medication. A unique consumer who uses a GoodRx code more than once in a calendar month to

purchase prescription medications is only counted as one Monthly Active Consumer in that month. A unique

consumer who uses a GoodRx code in two or three calendar months within a quarter will be counted as a

Monthly Active Consumer in each such month. Monthly Active Consumers do not include subscribers to our

subscription offerings, consumers of our pharma manufacturer solutions offering, or consumers who used our

telehealth offering. When presented for a period longer than a month, Monthly Active Consumers is averaged

over the number of calendar months in such period. For example, a unique consumer who uses a GoodRx

code twice in January, but who did not use our prescription transactions offering again in February or March, is

counted as 1 in January and as 0 in both February and March, thus contributing 0.33 to our Monthly Active

Consumers for such quarter (average of 1, 0 and 0). A unique consumer who uses a GoodRx code in January

and in March, but did not use our prescription transactions offering in February, would be counted as 1 in

January, 0 in February and 1 in March, thus contributing 0.66 to our Monthly Active Consumers for such

quarter. Monthly Active Consumers from acquired companies are only included beginning in the first full

quarter following the acquisition.

•“Monthly Visitors” refers to the number of individuals who visited our apps and websites in a given calendar

month. Visitors to our apps and websites are counted independently. As a result, a consumer that visits or

engages with our platform through both apps and websites will be counted multiple times in calculating

Monthly Visitors, while family members who use a single computer to visit our websites will be counted only

once. Additionally, Monthly Active Consumers who use a GoodRx code without accessing our apps or websites

(since their GoodRx codes were saved in their profile at the pharmacy), will not be counted as Monthly Visitors.

When presented for a period longer than a calendar month, Monthly Visitors is averaged over each calendar

month in such period.

•"partner pharmacies" refers to select licensed pharmacies with whom we have direct contractual agreements.

•“PBM” refers to a pharmacy benefit manager. PBMs aggregate demand to negotiate prescription medication

prices with pharmacies and pharma manufacturers. PBMs find most of their demand through relationships with

insurance companies and employers. However, nearly all PBMs also have consumer direct or cash network

pricing that they negotiate with pharmacies for consumers who choose to purchase prescriptions outside of

insurance.

•“pharma” is an abbreviation for pharmaceutical.

•“savings,” “saved” and similar references refer to the difference between the list price for a particular

prescription at a particular pharmacy and the price paid by the GoodRx consumer for that prescription utilizing

a GoodRx code available through our platform at that same pharmacy. In certain circumstances, we may show

a list price on our platform when such list price is lower than the negotiated price available using a GoodRx

code and, in certain circumstances, a consumer may use a GoodRx code and pay the list price at a pharmacy

if such list price is lower than the negotiated price available using a GoodRx code. We do not earn revenue

from such transactions, but our savings calculation includes an estimate of the savings achieved by the

consumer because our platform has directed the consumer to the pharmacy with the low list price. This

estimate of savings when the consumer pays the list price is based on internal data and is calculated as the

difference between the average list price across all pharmacies where GoodRx consumers paid the list price

and the average list price paid by consumers in the pharmacies to which we directed them. We do not

calculate savings based on insurance prices as we do not have information about a consumer’s specific

coverage or price. We do not believe savings are representative or indicative of our revenue or results of

•“subscribers” and similar references refers to our consumers that are subscribed to either of our subscription

offerings, Gold or Kroger Savings (which sunset in July 2024). References to subscription plans as of a

particular date represents an active subscription to either one of our aforementioned subscription offerings as

of the specified date. Each subscription plan may represent more than one subscriber since family subscription

plans may include multiple members.

•“Silver Lake” and similar references refer to investment funds associated with Silver Lake Partners, including

SLP Geology Aggregator, L.P.

•“Spectrum” refers to investment funds associated with Spectrum Equity, including Spectrum Equity VII, L.P.,

Spectrum VII Investment Managers’ Fund, L.P., Spectrum VII Co-Investment Fund, L.P.

Certain monetary amounts, percentages, and other figures included in this Annual Report on Form 10-K have been

subject to rounding adjustments. Percentage amounts included in this Annual Report on Form 10-K have not in all cases

been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. For this reason,

percentage amounts in this Annual Report on Form 10-K may vary from those obtained by performing the same calculations

using the figures in our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. Certain

other amounts that appear in this Annual Report on Form 10-K may not sum due to rounding.

Forward-Looking Statements

This Annual Report on Form 10-K contains forward-looking statements. We intend such forward-looking statements to

be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of

1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the

“Exchange Act”). All statements other than statements of historical facts contained in this Annual Report on Form 10-K may

be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,”

“should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,”

“forecasts,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. Forward-looking

statements contained in this Annual Report on Form 10-K include, but are not limited to statements regarding our future

results ofoperations and financial position, industry and business trends, the anticipated impact of ongoing changes in the

U.S. retail pharmacy landscape, our value proposition, our collaborations and partnerships with third parties, including our

integrated savings program, our direct contracting approach with select pharmacies, the impact of the sunset of certain of

our offerings, anticipated impacts of our restructuring and cost savings initiatives, the impact of a grocery chain not

accepting PBM pricing ("grocer issue") on our future results of operations, stock compensation, our new stock repurchase

program, realizability of deferred tax assets, potential outcomes and estimated impacts of certain legal proceedings, our

business strategy, our plans, market opportunity and growth and our objectives for future operations.

The forward-looking statements in this Annual Report on Form 10-K are only predictions. We have based these forward-

looking statements largely on our current expectations and projections about future events and financial trends that we

believe may affect our business, financial condition and results of operations. Forward-looking statements involve known

and unknown risks, uncertainties and other important factors that may cause our actual results, performance or

achievements to be materially different from any future results, performance or achievements expressed or implied by the

forward-looking statements, including, but not limited to, the important factors discussed in Part I, Item 1A, “Risk Factors” in

this Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The forward-looking statements in this

Annual Report on Form 10-K are based upon information available to us as of the date of this Annual Report on Form 10-K,

and while we believe such information forms a reasonable basis for such statements, such information may be limited or

incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review

of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to

unduly rely upon these statements.

You should read this Annual Report on Form 10-K and the documents that we reference in this Annual Report on Form

10-K and have filed as exhibits to this Annual Report on Form 10-K with the understanding that our actual future results,

levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our

forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of

this Annual Report on Form 10-K. Except as required by applicable law, we do not plan to publicly update or revise any

forward-looking statements contained in this Annual Report on Form 10-K, whether as a result of any new information, future

events or otherwise.

Additionally, any discussion of certain environmental, social and governance (“ESG”) assessments, goals and relevant

issues in our filings with the Securities and Exchange Commission (the “SEC”), including this filing, or other locations, such

as our corporate website, is informed by various ESG standards and frameworks (including standards for the measurement

of underlying data) and the interests of various stakeholders. As such, such information may not be, and should not be

interpreted as necessarily being, “material” under the federal securities laws for SEC reporting purposes. Furthermore, much

of this information is subject to assumptions, estimates or third-party information that is still evolving and subject to change.

For additional information, please see Part I, Item 1A, “Risk Factors – The increasing focus on ESG initiatives could increase

our costs, harm our reputation and adversely impact our financial results.”

Summary Risk Factors

Our business is subject to numerous risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors”

in this Annual Report on Form 10-K. You should carefully consider these risks and uncertainties when investing in our Class

A common stock. The principal risks and uncertainties affecting our business include the following:

•Risks related to our limited operating history andrecent growth rates could materially adversely impact our

business, financial condition, and results of operations;

•We may be unsuccessful in achieving broad market education and changing consumer purchasing habits;

•We may be unable to continue to attract, acquire and retain consumers, or may fail to do so in a cost-effective

manner;

•We rely significantly on our prescription transactions offering and may not be successful in expanding our

offerings within our markets, particularly the U.S. prescriptions market, or to other segments of the healthcare

industry;

•Our business is subject to changes in medication pricing and is significantly impacted by pricing structures

negotiated by industry participants;

•We generally do not control the categories and types of prescriptions for which we can offer savings or

discounted prices;

•We rely on a limited number of industry participants;

•We operate in a very competitive industry and we may fail to effectively differentiate our offerings and services

from those of our competitors, which could impair our ability to attract and acquire new consumers and retain

existing consumers;

•Our estimated addressable market is subject to inherent challenges and uncertainties. If we overestimate the

size of our addressable market or the various markets in which we operate, our future growth opportunities

may be limited;

•We calculate certain operational metrics using internal systems and tools and do not independently verify such

metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies

in such metrics may harm our reputation and negatively affect our business;

•We may be unable to successfully respond to changes in the market for prescription pricing, and may fail to

maintain and expand the use of GoodRx codes through our apps and websites;

•We may be unable to maintain a positive perception regarding our platform or maintain and enhance our

brand;

•We are obligated to maintain effective internal control over financial reporting and any failure to maintain

effective internal controls may cause us to not be able to accurately report our financial condition or results of

operations, which may adversely affect investor confidence in our company and, as a result, the value of our

Class A common stock;

•Use of social media, emails and text messages may adversely impact our reputation, subject us to fines or

other penalties or be an ineffective source to market our offerings;

•We depend on our information technology systems, and those of our third-party vendors, contractors and

consultants, and any failure or significant disruptions of these systems, security breaches or loss of data could

materially adversely affect our business, financial condition and results of operations;

•Government regulation of the internet and e-commerce is evolving, and unfavorable changes or failure by us to

comply with these laws and regulations could substantially harm our business and results of operations;

•Our business relies on email, mail and other messaging channels and any technical, legal or other restrictions

on the sending of such correspondence or a decrease in consumer willingness to receive such

correspondence could adversely affect our business;

•We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone

Consumer Protection Act;

•Actual or perceived failures to comply with applicable data protection, privacy and security, advertising and

consumer protection laws, regulations, standards and other requirements could adversely affect our business,

financial condition and results of operations;

•We may be unable to realize expected benefits from our restructuring and cost reduction efforts and our

business might be adversely affected;

•Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited;

•We rely on the performance of members of management and highly skilled personnel, and if we are unable to

attract, develop, motivate and retain well-qualified employees, our business could be harmed;

•A pandemic, epidemic or outbreak of an infectious disease in the United States, has and could in the future

adversely impact our business;

•We may seek to grow our business through acquisitions of, or investments in, new or complementary

businesses, technologies or products, or through strategic alliances, and the failure to manage these

acquisitions, investments or alliances, or to integrate them with our existing business, could have a material

adverse effect on us;

•Restrictions in our debt arrangements could adversely affect our operating flexibility, and failure to comply with

any of these restrictions could result in acceleration of our debt;

•Our business depends on network and mobile infrastructure and our ability to maintain and scale our

technology. Any significant interruptions or delays in service on our apps or websites or any undetected errors

or design faults could result in limited capacity, reduced demand, processing delays and loss of consumers;

•We depend on our relationships with third parties and would be adversely impacted by system failures or other

disruptions in the operations of these parties;

•Changes in consumer sentiment or laws, rules or regulations regarding the use of cookies and other tracking

technologies and other privacy matters could have a material adverse effect on our ability to generate

revenues and could adversely affect our ability to collect proprietary data on consumer behavior;

•We are subject to a series of risks related to climate change;

•The increasing focus on environmental, social and governance initiatives could increase our costs, harm our

reputation and adversely impact our financial results;

•Risks related to our intellectual property could materially adversely impact our business, competitive position,

financial condition, and results of operations;

•Risks related to the healthcare industry, as well as the impact of healthcare reform legislation and other

proposed or future changes, could materially adversely impact our business, financial condition, and results of

operations;

•Risks related to our organizational structure, including agreements and relationships with significant

stockholders, could materially adversely impact our business, financial condition and results of operations;

•We are, and may become in the future, subject to various legal proceedings and claims that arise in or outside

the ordinary course of business, which may require significant management time and attention, result in

significant legal expenses and may result in unfavorable outcomes, which may have a material adverse effect

on our business, operating results and financial condition, and negatively affect the price of our Class A

common stock; and

•We may be unable to accurately forecast revenue and appropriately plan our expenses in the future.